The AP-1 binding sites located in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity by Vandenhoudt, Nathalie et al.
The AP-1 binding sites located in the pol gene
intragenic regulatory region of HIV-1 are important for
virus infectivity
Nathalie Vandenhoudt, Ste´phane De Walque, Benoˆıt Van Driessche, Laurence
Colin, Vale´rie Martinelli, Allan Guiguen, Caroline Vanhulle, Arse`ne Burny,
Georges Herbein, Olivier Rohr, et al.
To cite this version:
Nathalie Vandenhoudt, Ste´phane De Walque, Benoˆıt Van Driessche, Laurence Colin, Vale´rie
Martinelli, et al.. The AP-1 binding sites located in the pol gene intragenic regulatory region
of HIV-1 are important for virus infectivity. Frontiers of Retrovirology: Complex retroviruses,
retroelements and their hosts, Sep 2009, Montpellier, France. BioMed Central, 6 (Suppl 2),
pp.P89, 2009, Retrovirology. <10.1186/1742-4690-6-S2-P89>. <inserm-00663598>
HAL Id: inserm-00663598
http://www.hal.inserm.fr/inserm-00663598
Submitted on 27 Jan 2012
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destine´e au de´poˆt et a` la diffusion de documents
scientifiques de niveau recherche, publie´s ou non,
e´manant des e´tablissements d’enseignement et de
recherche franc¸ais ou e´trangers, des laboratoires
publics ou prive´s.

BioMed Central
Page 1 of 1
(page number not for citation purposes)
Retrovirology
Open AccessPoster presentation
The AP-1 binding sites located in the pol gene intragenic regulatory 
region of HIV-1 are important for virus infectivity
Nathalie Vandenhoudt*1, Stéphane de Walque1, Benoît Van Driessche1, 
Laurence Colin1, Valérie Martinelli1, Allan Guiguen1, Caroline Vanhulle1, 
Arsène Burny1, Georges Herbein2, Olivier Rohr3 and Carine Van Lint1
Address: 1Laboratory of Molecular Virology, Institut de Biologie et de Médecine Moléculaires (IBMM), Université Libre de Bruxelles (ULB), 6041 
Gosselies, Belgium, 2Department of Virology, University of Franche-Comte, St-Jacques Hospital, 25030 Besançon, France and 3INSERM U575, 
Virology Institute, 67000 Strasbourg, France
* Corresponding author    
We have previously identified three AP-1 binding sites in
the pol gene of human immunodeficiency virus type 1
(HIV-1) and shown that short oligonucleotides contain-
ing these sites functioned as phorbol ester-inducible
enhancers (Van Lint et al., 1991, J. Virol., 65:7066-7072).
These sites are located in a region, called fragment 5103,
exhibiting a phorbol ester-inducible enhancing activity on
the viral thymidine kinase promoter in HeLa cells. In this
study, we have further characterized each of the AP-1
binding sites and have shown that transcription factors c-
Fos, JunB and JunD interacted in vitro with these motifs.
For each site, we have identified mutations abolishing AP-
1 factor binding without altering the underlying amino
acid sequence of the HIV-1 reverse transcriptase. By tran-
sient transfection assays, we have demonstrated that the
intragenic AP-1 binding sites were entirely responsible for
the PMA-dependent transcriptional activity of fragment
5103. Moreover, this PMA-stimulated activity of fragment
5103 was inhibited by a dominant-negative A-Fos mutant
provided the AP-1 sites were not mutated. Finally, we have
investigated the biological significance of the intragenic
AP-1 binding sites in HIV-1 replication and have shown
that these sites are important for viral infectivity.
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